Palisade Bio
PALI
21 hedge funds and large institutions have $1.7M invested in Palisade Bio in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
40% more funds holding
Funds holding: 15 → 21 (+6)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
16% less capital invested
Capital invested by funds: $2.03M → $1.7M (-$333K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$778K |
| 2 |
Renaissance Technologies
New York
|
+$189K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$85.6K |
| 4 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$57.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$54.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$47K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$44K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$28K |
| 4 |
BlackRock
New York
|
-$14K |
PALI Hedge Fund Activity: Q4 2021 in Review
21 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2021, worth a combined $1.7M — down 16% from $2.03M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PALI positions and 3 closed out — a net gain of 6 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $778K. The largest seller was Virtu Financial, exiting entirely with an estimated $47K sold.
- 21 institutional investors held Palisade Bio (PALI) as of Q4 2021, up from 15 in Q3 2021.
- Funds reported $1.7M of Palisade Bio stock for Q4 2021, down 16% quarter-over-quarter.
- 9 funds opened new Palisade Bio positions in Q4 2021 and 3 closed out, a net change of +6 holders.
- The largest Palisade Bio buyer in Q4 2021 was Altium Capital Management, an estimated $778K added.
- The largest Palisade Bio seller in Q4 2021 was Virtu Financial, an estimated $47K sold.
Based on aggregated 13F filings for Q4 2021.